← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mattek Corporation
Ashland, MA
$23,987,410
Total funding
42
Grants
Funding over time
peak $2.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$23,987,410 · 42
By mechanism
R44$13,836,985 · 15
R43$5,144,394 · 24
U01$3,362,326 · 1
U44$1,203,353 · 1
R21$440,352 · 1
Investigators at Mattek Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$937,758
U01 · FY2009 · AI
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$648,815
R44 · FY2016 · GM
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$619,724
U01 · FY2010 · AI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$606,651
U01 · FY2006 · AI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$601,624
U01 · FY2008 · AI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$596,569
U01 · FY2007 · AI
Human Tissue Model For Heterosexual HIV Transmission$539,631
R44 · FY2003 · AI
Validation of an In Vitro Human Airway Model$537,491
R44 · FY2012 · ES
Human Tissue Model For Heterosexual HIV Transmission$533,386
R44 · FY2002 · AI
Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing$530,965
U44 · FY2018 · ES
Validation of a Human In Vitro Vaginal Irritation Test$516,667
R44 · FY2009 · HD
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$507,987
R44 · FY2017 · GM
Validation of a Human In Vitro Vaginal Irritation Test$491,867
R44 · FY2010 · HD
Genetically modified tissue engineered in vitro human models$483,227
R44 · FY2013 · GM
Genetically modified tissue engineered in vitro human models$483,227
R44 · FY2012 · GM
Reconstructed Human Oral Tissues$482,896
R44 · FY2003 · DE
High-Throughput Screening of Therapeutics$476,109
R44 · FY2002 · ES
In Vitro Assay for Chemical Allergens$475,043
R44 · FY2007 · CA
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors$460,766
R44 · FY2012 · ES
Reconstruction of skin model containing Langerhans cells$456,320
R44 · FY2002 · AR